---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-003523"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2022-02-23T23:59:59+00:00"
generated_at: "2026-06-27T05:47:47.890109+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medifast Q4 revenue $377.8M (+42.6%); FY 2021 revenue $1.526B (+63.2%)

## Summary
- Q4 diluted EPS $2.91 vs $2.36 YoY; net income $34.0M (+21.5%).
- Active earning OPTA VIA Coaches up 35.3% to 59,800; revenue per coach $6,321.
- FY 2022 guidance: revenue $1.72B-$1.79B; diluted EPS $14.50-$16.00.
- Cash and investments $109.5M; no interest-bearing debt; $16.8M dividend paid Feb 8.
- Repurchased $56M of stock in FY 2021; $10M in Q4 alone.

## SEC filing metadata
- accession: 0001628280-22-003523
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2022-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/0001628280-22-003523-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/med-20220223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-003523
- JSON: https://secwatch.observer/filing/0001628280-22-003523.json
- Plain text: https://secwatch.observer/filing/0001628280-22-003523.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.